메뉴 건너뛰기




Volumn 13, Issue 1, 2013, Pages

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer

Author keywords

c MET; EGFR TKI; Integrin beta1; Non small cell lung cancer; Resistance

Indexed keywords

BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; GEFITINIB; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR;

EID: 84874345759     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-15     Document Type: Article
Times cited : (31)

References (33)
  • 1
    • 78649762711 scopus 로고    scopus 로고
    • Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    • 10.1002/jcb.22888, 21053345
    • Ju L, Zhou C, Li W, Yan L. Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer. J Cell Biochem 2010, 111:1565-1574. 10.1002/jcb.22888, 21053345.
    • (2010) J Cell Biochem , vol.111 , pp. 1565-1574
    • Ju, L.1    Zhou, C.2    Li, W.3    Yan, L.4
  • 2
    • 84859598676 scopus 로고    scopus 로고
    • β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
    • 10.1172/JCI61350, 3314473, 22378044
    • Eke I, Deuse Y, Hehlgans SK, Gurtner K, Krause M, Baumann M, Shevchenko A, Sandfort V, Cordes N. β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Invest 2012, 122:1529-1540. 10.1172/JCI61350, 3314473, 22378044.
    • (2012) J Clin Invest , vol.122 , pp. 1529-1540
    • Eke, I.1    Deuse, Y.2    Hehlgans, S.K.3    Gurtner, K.4    Krause, M.5    Baumann, M.6    Shevchenko, A.7    Sandfort, V.8    Cordes, N.9
  • 3
    • 84861203790 scopus 로고    scopus 로고
    • The alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through the extracellular-signal-regulated kinase (ERK)
    • 10.1074/jbc.M112.349365, 22457358
    • Naci D, Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D, Al-Daccak R, Aoudjit F. The alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through the extracellular-signal-regulated kinase (ERK). J Biol Chem 2012, 287:17065-17076. 10.1074/jbc.M112.349365, 22457358.
    • (2012) J Biol Chem , vol.287 , pp. 17065-17076
    • Naci, D.1    Azreq, M.A.2    Chetoui, N.3    Lauden, L.4    Sigaux, F.5    Charron, D.6    Al-Daccak, R.7    Aoudjit, F.8
  • 7
    • 36749044792 scopus 로고    scopus 로고
    • EGFR and beta1 integrins utilize different signaling pathways to activate Akt
    • 10.1016/j.yexcr.2007.08.018, 17910952
    • Velling T, Stefansson A, Johansson S. EGFR and beta1 integrins utilize different signaling pathways to activate Akt. Exp Cell Res 2008, 314:309-316. 10.1016/j.yexcr.2007.08.018, 17910952.
    • (2008) Exp Cell Res , vol.314 , pp. 309-316
    • Velling, T.1    Stefansson, A.2    Johansson, S.3
  • 8
    • 3042646119 scopus 로고    scopus 로고
    • Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin
    • 10.1242/jcs.01057, 15126624
    • Wu Y, Chen L, Cao L, Sheng W, Yang BB. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin. J Cell Sci 2004, 117:2227-2237. 10.1242/jcs.01057, 15126624.
    • (2004) J Cell Sci , vol.117 , pp. 2227-2237
    • Wu, Y.1    Chen, L.2    Cao, L.3    Sheng, W.4    Yang, B.B.5
  • 9
    • 0033623969 scopus 로고    scopus 로고
    • Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation
    • 14934, 10888683
    • Kuwada SK, Li X. Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation. Mol Biol Cell 2000, 11:2485-2496. 14934, 10888683.
    • (2000) Mol Biol Cell , vol.11 , pp. 2485-2496
    • Kuwada, S.K.1    Li, X.2
  • 11
    • 0031854558 scopus 로고    scopus 로고
    • The roles of hepatocyte growth factor/scatter factor and MET receptor in human cancers
    • To CT, Tsao MS. The roles of hepatocyte growth factor/scatter factor and MET receptor in human cancers. Oncol Rep 1998, 5:1013-1024.
    • (1998) Oncol Rep , vol.5 , pp. 1013-1024
    • To, C.T.1    Tsao, M.S.2
  • 12
    • 0032730169 scopus 로고    scopus 로고
    • HGF: A multifunctional growth factor controlling cell scattering
    • Stella MC, Comoglio PM. HGF: A multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol 1999, 12:1357-1362.
    • (1999) Int J Biochem Cell Biol , vol.12 , pp. 1357-1362
    • Stella, M.C.1    Comoglio, P.M.2
  • 16
    • 25444495268 scopus 로고    scopus 로고
    • Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified MET-integrin induced signalling pathway in endothelial cells
    • 10.1186/1471-2121-6-8, 553973, 15717924
    • Rahman S, Patel Y, Murray J, Patel KV, Sumathipala R, Sobel M, Wijelath ES. Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified MET-integrin induced signalling pathway in endothelial cells. BMC Cell Biol 2005, 6:8. 10.1186/1471-2121-6-8, 553973, 15717924.
    • (2005) BMC Cell Biol , vol.6 , pp. 8
    • Rahman, S.1    Patel, Y.2    Murray, J.3    Patel, K.V.4    Sumathipala, R.5    Sobel, M.6    Wijelath, E.S.7
  • 17
    • 43549127378 scopus 로고    scopus 로고
    • Crosstalk between the α2β1 integrin and c-MET/HGF-R regulates innate immunity
    • 10.1182/blood-2007-08-107664, 2275022, 18198349
    • McCall-Culbreath KD, Li Z, Zutter MM. Crosstalk between the α2β1 integrin and c-MET/HGF-R regulates innate immunity. Blood 2008, 111:3562-3570. 10.1182/blood-2007-08-107664, 2275022, 18198349.
    • (2008) Blood , vol.111 , pp. 3562-3570
    • McCall-Culbreath, K.D.1    Li, Z.2    Zutter, M.M.3
  • 18
    • 20644433937 scopus 로고    scopus 로고
    • Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
    • 10.1002/ijc.20985, 15761868
    • Koizumi F, Shimoyama T, Taguchi F, Saijo N, Nishio K. Establishment of a human non-small cell lung cancer cell line resistant to gefitinib. Int J Cancer 2005, 116:36-44. 10.1002/ijc.20985, 15761868.
    • (2005) Int J Cancer , vol.116 , pp. 36-44
    • Koizumi, F.1    Shimoyama, T.2    Taguchi, F.3    Saijo, N.4    Nishio, K.5
  • 19
    • 64849086921 scopus 로고    scopus 로고
    • Synergism of EGFR and c-MET pathways, cross-talk and inhibition, in non-small cell lung cancer
    • 10.4103/1477-3163.44372, 2669728, 19240370
    • Puri N, Salgia R. Synergism of EGFR and c-MET pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog 2008, 7:9. 10.4103/1477-3163.44372, 2669728, 19240370.
    • (2008) J Carcinog , vol.7 , pp. 9
    • Puri, N.1    Salgia, R.2
  • 20
    • 33746789922 scopus 로고    scopus 로고
    • Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations
    • 10.1200/JCO.2005.05.4692, 16785471
    • Inoue A, Suzuki T, Fukuhara T, Maemondo M, Kimura Y, Morikawa N, Watanabe H, Saijo Y, Nukiwa T. Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations. J Clin Oncol 2006, 24:3340-3346. 10.1200/JCO.2005.05.4692, 16785471.
    • (2006) J Clin Oncol , vol.24 , pp. 3340-3346
    • Inoue, A.1    Suzuki, T.2    Fukuhara, T.3    Maemondo, M.4    Kimura, Y.5    Morikawa, N.6    Watanabe, H.7    Saijo, Y.8    Nukiwa, T.9
  • 21
    • 33845262077 scopus 로고    scopus 로고
    • Gefitinib for nonsmall-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp
    • 10.1038/sj.bjc.6603466, 2360739, 17106442
    • Sutani A, Nagai Y, Udagawa K, Uchida Y, Koyama N, Murayama Y, Tanaka T, Miyazawa H, Nagata M, Kanazawa M, Hagiwara K, Kobayashi K. Gefitinib for nonsmall-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp. Br J Cancer 2006, 95:1483-1489. 10.1038/sj.bjc.6603466, 2360739, 17106442.
    • (2006) Br J Cancer , vol.95 , pp. 1483-1489
    • Sutani, A.1    Nagai, Y.2    Udagawa, K.3    Uchida, Y.4    Koyama, N.5    Murayama, Y.6    Tanaka, T.7    Miyazawa, H.8    Nagata, M.9    Kanazawa, M.10    Hagiwara, K.11    Kobayashi, K.12
  • 25
    • 70449507354 scopus 로고    scopus 로고
    • Beta1 integrin targeting to enhance radiation therapy
    • 10.3109/09553000903232876, 19895268
    • Nam JM, Chung Y, Hsu HC, Park CC. beta1 integrin targeting to enhance radiation therapy. Int J Radiat Biol 2009, 85:923-928. 10.3109/09553000903232876, 19895268.
    • (2009) Int J Radiat Biol , vol.85 , pp. 923-928
    • Nam, J.M.1    Chung, Y.2    Hsu, H.C.3    Park, C.C.4
  • 26
    • 72249105509 scopus 로고    scopus 로고
    • Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer
    • 10.1158/0008-5472.CAN-09-1591, 19887601
    • Lesniak D, Xu Y, Deschenes J, Lai R, Thoms J, Murray D, Gosh S, Mackey JR, Sabri S, Abdulkarim B. Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer. Cancer Res 2009, 69:8620-8628. 10.1158/0008-5472.CAN-09-1591, 19887601.
    • (2009) Cancer Res , vol.69 , pp. 8620-8628
    • Lesniak, D.1    Xu, Y.2    Deschenes, J.3    Lai, R.4    Thoms, J.5    Murray, D.6    Gosh, S.7    Mackey, J.R.8    Sabri, S.9    Abdulkarim, B.10
  • 27
    • 77953504466 scopus 로고    scopus 로고
    • Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line
    • 10.3109/10428191003746315, 20470221
    • Wang G, Chen X, Geng Q, Jie L, Gui-Nan L, Yue L. Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line. Leuk Lymphoma 2010, 51:1090-1097. 10.3109/10428191003746315, 20470221.
    • (2010) Leuk Lymphoma , vol.51 , pp. 1090-1097
    • Wang, G.1    Chen, X.2    Geng, Q.3    Jie, L.4    Gui-Nan, L.5    Yue, L.6
  • 28
    • 83355163335 scopus 로고    scopus 로고
    • Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype
    • 10.1158/1535-7163.MCT-11-0149, 3237739, 21980133
    • Emmons MF, Gebhard AW, Nair RR, Baz R, McLaughlin ML, Cress AE, Hazlehurst LA. Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype. Mol Cancer Ther 2011, 10:2257-2266. 10.1158/1535-7163.MCT-11-0149, 3237739, 21980133.
    • (2011) Mol Cancer Ther , vol.10 , pp. 2257-2266
    • Emmons, M.F.1    Gebhard, A.W.2    Nair, R.R.3    Baz, R.4    McLaughlin, M.L.5    Cress, A.E.6    Hazlehurst, L.A.7
  • 29
    • 35348995145 scopus 로고    scopus 로고
    • Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells
    • Estrugo D, Fischer A, Hess F, Scherthan H, Belka C, Cordes N. Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells. PLoS One 2007, 2:69.
    • (2007) PLoS One , vol.2 , pp. 69
    • Estrugo, D.1    Fischer, A.2    Hess, F.3    Scherthan, H.4    Belka, C.5    Cordes, N.6
  • 30
    • 33748286819 scopus 로고    scopus 로고
    • Integrin-regulated FAK-Src signaling in normal and cancer cells
    • 10.1016/j.ceb.2006.08.011, 16919435
    • Mitra SK, Schlaepfer D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006, 18:516-523. 10.1016/j.ceb.2006.08.011, 16919435.
    • (2006) Curr Opin Cell Biol , vol.18 , pp. 516-523
    • Mitra, S.K.1    Schlaepfer, D.2
  • 32
    • 79953220086 scopus 로고    scopus 로고
    • Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis
    • 10.1038/onc.2010.532, 3069218, 21119598
    • Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E. Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 2011, 30:1566-1576. 10.1038/onc.2010.532, 3069218, 21119598.
    • (2011) Oncogene , vol.30 , pp. 1566-1576
    • Mitra, A.K.1    Sawada, K.2    Tiwari, P.3    Mui, K.4    Gwin, K.5    Lengyel, E.6
  • 33
    • 0032735443 scopus 로고    scopus 로고
    • HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells
    • 10.1002/(SICI)1097-0215(19991126)83:5<640::AID-IJC13>3.0.CO;2-D, 10521801
    • Beviglia L, Kramer RH. HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells. Int J Cancer 1999, 83:640-649. 10.1002/(SICI)1097-0215(19991126)83:5<640::AID-IJC13>3.0.CO;2-D, 10521801.
    • (1999) Int J Cancer , vol.83 , pp. 640-649
    • Beviglia, L.1    Kramer, R.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.